Atlas Trials

Presurgical Therapy With Lapatinib to Explore Molecular Determinants of Response to EGFR/erbB2 Targeted Therapy

Clinical trial NCT00343759 · WITHDRAWN

Trial details

NCT number
NCT00343759
Sponsor
University of Pennsylvania
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Breast Cancer
Start date
2006-06-01
Primary completion
2009-05-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.